TIM-4 is Expressed on Invariant NKT Cells but Dispensable for Their Development and Function

Overview

Journal Oncotarget

Specialty Oncology

Date 2016 Sep 24

PMID 27662666

Citations 8

Authors

Xilin Zhang

Jun Gu

Li Zhou

Qing-Sheng Mi

Affiliations

Soon will be listed here.

Abstract

T cell immunoglobulin and mucin-4 (TIM-4), mainly expressed on antigen presenting cells, plays a versatile role in immunoregulation. CD1d-restricted invariant natural killer T (iNKT) cells are potent cells involved in the diverse immune responses. It was recently reported that recombinant TIM-4 (rTIM-4) alone enhanced cytokine production in NKT hybridoma, DN32.D3 cells. Hence, we hypothesized that TIM-4 might regulate iNKT cell biology, especially their function of cytokine secretion. For the first time, we identified that TIM-4 was expressed in thymus iNKT cells, and its expression increased upon iNKT cell migration to the secondary lymphoid organs, especially in lymph nodes. Using TIM-4-deficient mice, we found that lack of TIM-4 did not disturb iNKT cell development, maturation, peripheral homeostasis and cytokine secretion. Moreover, TIM-4 deficiency did not alter the polarization of iNKT sublineages, including NKT1, NKT2 and NKT17. Finally, the mixed bone marrow transfer experiments further confirmed normal iNKT cell development and function from TIM-4-deficient bone marrow. In conclusion, our data suggest that TIM-4 is expressed on iNKT cells but dispensable for their development and function.

Citing Articles

IRG1/itaconate enhances efferocytosis by activating Nrf2-TIM4 signaling pathway to alleviate con A induced autoimmune liver injury.

Zeng L, Wang Y, Huang Y, Yang W, Zhou P, Wan Y Cell Commun Signal. 2025; 23(1):63.

PMID: 39910615 PMC: 11796036. DOI: 10.1186/s12964-025-02075-5.

TIM-4 increases the proportion of CD4CD25FOXP3 regulatory T cells in the pancreatic ductal adenocarcinoma microenvironment by inhibiting IL-6 secretion.

Wang Z, Xie Z, Mou Y, Geng R, Chen C, Ke N Cancer Med. 2024; 13(17):e70110.

PMID: 39235042 PMC: 11375529. DOI: 10.1002/cam4.70110.

Tim-4 alleviates acute hepatic injury by modulating homeostasis and function of NKT cells.

Wang Y, Wang Y, Ge Y, Wu Z, Yue X, Li C Clin Exp Immunol. 2024; 218(1):101-110.

PMID: 39036980 PMC: 11404119. DOI: 10.1093/cei/uxae063.

Recipient signaling regulates ischemia reperfusion-induced ER stress and metabolic responses in liver transplantation: from mouse-to-human.

Hirao H, Kageyama S, Nakamura K, Kadono K, Kojima H, Siyuan Y Front Transplant. 2024; 2:1176384.

PMID: 38993869 PMC: 11235257. DOI: 10.3389/frtra.2023.1176384.

Function and characteristics of TIM‑4 in immune regulation and disease (Review).

Wang Z, Chen C, Su Y, Ke N Int J Mol Med. 2022; 51(2).

PMID: 36524355 PMC: 9848438. DOI: 10.3892/ijmm.2022.5213.

References

Park D, Hochreiter-Hufford A, Ravichandran K . The phosphatidylserine receptor TIM-4 does not mediate direct signaling. Curr Biol. 2009; 19(4):346-51. DOI: 10.1016/j.cub.2009.01.042. View

Berzins S, McNab F, Jones C, Smyth M, Godfrey D . Long-term retention of mature NK1.1+ NKT cells in the thymus. J Immunol. 2006; 176(7):4059-65. DOI: 10.4049/jimmunol.176.7.4059. View

Godfrey D, MacDonald H, Kronenberg M, Smyth M, Van Kaer L . NKT cells: what's in a name?. Nat Rev Immunol. 2004; 4(3):231-7. DOI: 10.1038/nri1309. View

Kuchroo V, Umetsu D, DeKruyff R, Freeman G . The TIM gene family: emerging roles in immunity and disease. Nat Rev Immunol. 2003; 3(6):454-62. DOI: 10.1038/nri1111. View

Santiago C, Ballesteros A, Tami C, Martinez-Munoz L, Kaplan G, Casasnovas J . Structures of T Cell immunoglobulin mucin receptors 1 and 2 reveal mechanisms for regulation of immune responses by the TIM receptor family. Immunity. 2007; 26(3):299-310. PMC: 7111020. DOI: 10.1016/j.immuni.2007.01.014. View

Tang Z, Liang S, Potter J, Jiang X, Mao H, Li Z . Tim-3/galectin-9 regulate the homeostasis of hepatic NKT cells in a murine model of nonalcoholic fatty liver disease. J Immunol. 2013; 190(4):1788-96. PMC: 3563933. DOI: 10.4049/jimmunol.1202814. View

Shakhov A, Rybtsov S, Tumanov A, Shulenin S, Dean M, Kuprash D . SMUCKLER/TIM4 is a distinct member of TIM family expressed by stromal cells of secondary lymphoid tissues and associated with lymphotoxin signaling. Eur J Immunol. 2004; 34(2):494-503. DOI: 10.1002/eji.200324590. View

Barral P, Polzella P, Bruckbauer A, van Rooijen N, Besra G, Cerundolo V . CD169(+) macrophages present lipid antigens to mediate early activation of iNKT cells in lymph nodes. Nat Immunol. 2010; 11(4):303-12. PMC: 2923071. DOI: 10.1038/ni.1853. View

Gapin L, Matsuda J, Surh C, Kronenberg M . NKT cells derive from double-positive thymocytes that are positively selected by CD1d. Nat Immunol. 2001; 2(10):971-8. DOI: 10.1038/ni710. View

10.

Feng B, Chen X, He S, Zheng P, Foster J, Xing Z . Disruption of T-cell immunoglobulin and mucin domain molecule (TIM)-1/TIM4 interaction as a therapeutic strategy in a dendritic cell-induced peanut allergy model. J Allergy Clin Immunol. 2008; 122(1):55-61, 61.e1-7. DOI: 10.1016/j.jaci.2008.04.036. View

11.

Taniguchi M, Koseki H, Tokuhisa T, Masuda K, Sato H, Kondo E . Essential requirement of an invariant V alpha 14 T cell antigen receptor expression in the development of natural killer T cells. Proc Natl Acad Sci U S A. 1996; 93(20):11025-8. PMC: 38277. DOI: 10.1073/pnas.93.20.11025. View

12.

Liu T, He S, Zheng P, Zhang T, Wang B, Yang P . Staphylococcal enterotoxin B increases TIM4 expression in human dendritic cells that drives naïve CD4 T cells to differentiate into Th2 cells. Mol Immunol. 2007; 44(14):3580-7. DOI: 10.1016/j.molimm.2007.03.004. View

13.

Berzofsky J, Terabe M . NKT cells in tumor immunity: opposing subsets define a new immunoregulatory axis. J Immunol. 2008; 180(6):3627-35. DOI: 10.4049/jimmunol.180.6.3627. View

14.

Cao W, Ryan M, Buckley D, OConnor R, Clarkson M . Tim-4 inhibition of T-cell activation and T helper type 17 differentiation requires both the immunoglobulin V and mucin domains and occurs via the mitogen-activated protein kinase pathway. Immunology. 2011; 133(2):179-89. PMC: 3088980. DOI: 10.1111/j.1365-2567.2011.03424.x. View

15.

Pellicci D, Hammond K, Uldrich A, Baxter A, Smyth M, Godfrey D . A natural killer T (NKT) cell developmental pathway iInvolving a thymus-dependent NK1.1(-)CD4(+) CD1d-dependent precursor stage. J Exp Med. 2002; 195(7):835-44. PMC: 2193721. DOI: 10.1084/jem.20011544. View

16.

Berzins S, Smyth M, Baxter A . Presumed guilty: natural killer T cell defects and human disease. Nat Rev Immunol. 2011; 11(2):131-42. DOI: 10.1038/nri2904. View

17.

Kim H, Eyheramonho M, Pichavant M, Gonzalez Cambaceres C, Matangkasombut P, Cervio G . A polymorphism in TIM1 is associated with susceptibility to severe hepatitis A virus infection in humans. J Clin Invest. 2011; 121(3):1111-8. PMC: 3049365. DOI: 10.1172/JCI44182. View

18.

Lee H, Meyer E, Goya S, Pichavant M, Kim H, Bu X . Apoptotic cells activate NKT cells through T cell Ig-like mucin-like-1 resulting in airway hyperreactivity. J Immunol. 2010; 185(9):5225-35. PMC: 3114419. DOI: 10.4049/jimmunol.1001116. View

19.

Kim H, Kim H, Lee C, Chung D . T cell Ig domain and mucin domain 1 engagement on invariant NKT cells in the presence of TCR stimulation enhances IL-4 production but inhibits IFN-gamma production. J Immunol. 2010; 184(8):4095-106. DOI: 10.4049/jimmunol.0901991. View

20.

Yeung M, McGrath M, Nakayama M, Shimizu T, Boenisch O, Magee C . Interruption of dendritic cell-mediated TIM-4 signaling induces regulatory T cells and promotes skin allograft survival. J Immunol. 2013; 191(8):4447-55. PMC: 3804420. DOI: 10.4049/jimmunol.1300992. View